ArticleCurrent research in structural biology2023
Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy.
Kundan Solanki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it